FXS6837

· Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FXS6837, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: FXS6837 for the Treatment of IgAN Patients [Phase 2]